HomeCLINICAL TRIALS, STUDIES, REGISTRIES, DATA
CLINICAL TRIALS, STUDIES, REGISTRIES, DATA
Clinical trials, studies, data, and updates reported in Medical Device News Magazine.
Enrollment in Tria LifePolymer Early Feasibility Study Completed: Included 15 Patients
Fifteen patients have been enrolled in the Tria LifePolymer early feasibility study reports FOLDAX.
Feinstein Institutes Begins Enrolling Patients in Multiple COVID-19 Clinical Trials
In an effort to treat patients currently suffering from COVID-19, researchers from Feinstein Institutes are collaborating on new clinical studies with biopharmaceutical leaders Gilead Sciences, Regeneron and Sanofi.
Smoking Cessation Multicenter Study Evaluating Use of Deep TMS at Society for Research on Nicotine & Tobacco 2020
The company recently presented positive data from its multicenter study evaluating the Company’s proprietary deep transcranial magnetic stimulation (Deep TMS) system as an aid in smoking cessation in an oral presentation at the Society for Research on Nicotine & Tobacco (SRNT) annual conference, which takes place March 11-14, 2020, in New Orleans, Louisiana.
Clinical Trial for Detection of Mild Traumatic Brain Injury in Children Commences
In this clinical trial, Medicortex seeks to collect a sufficient number of pediatric samples in order to prove the applicability of the brain injury test in children, as a natural continuation for previously proven clinical performance in adults.
Interim Efficacy Data from eCoin Pivotal Trial Reported
Valencia Technologies announced 6-month interim efficacy data from its eCoin Pivotal Clinical Trial. The announcement follows the podium presentation of the interim data at the Society of Urodynamics, Female Pelvic Medicine & Urogenital Reconstruction (SUFU) 2020 Annual Meeting on February 28th, 2020.
Completion of Study Enrolment of Implandata’s Extraocular Eye Pressure Sensor for Continual Glaucoma Monitoring
This first-in-human clinical study is conducted to validate the suprachoroidally placed EYEMATE-SC sensor implant for continual monitoring of intraocular pressure (IOP). The lead investigator Prof. Dr. med. Peter Szurman from Eye Sulzbach at Knappschaft Hospital Saar, Germany asserts: “The eye pressure sensor is pleasantly small and easy to implant, so most patients undergoing glaucoma surgery are eligible for such a pressure sensor. This enables glaucoma patients for the first time to monitor their own eye pressure at any time. It will improve the safety for glaucoma patients and significantly reduce the risk of blindness due to glaucoma.”
CorTechs Labs Presents Findings on the Creation of Machine Learning Models to Aid Early, Accurate Diagnosis of MS at ACTRIMS 2020
CorTechs Labs evaluated the performance of these models for identifying MS subjects and studied the differences of feature importance selected by the models based on whole and specific age range data.
First Patient Enrolled in Pivotal Atherectomy Clinical Study
Ra Medical received investigational device exemption (IDE) approval for the atherectomy clinical study from the FDA in January 2020.
FDA Approves to Continue the PROMISE Sensor Clinical Study in an Extended Cohort to 365 Days to Gather Feasibility Data
PROMISE Sensor Clinical Study is to evaluate the safety and efficacy of the Eversense CGM System in people with diabetes over a 180-day period for the pre-market application submission to the U.S.